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A successful pregnancy is critically dependent upon proper placental development and function, 
beginning with differentiation of human trophoblast cells. At the final stage of trophoblast 
differentiation, the human placenta contains a cell population called syncytiotrophoblasts which 
provide the exchange surface between the mother and the fetus. However, molecular regulation 
of syncytiotrophoblast development is poorly understood. In this study, we explored the 
regulatory pathway of lysine-specific demethylase 1 (LSD1), in combination with transcription 
factor GATA2 and cellular signaling, in human trophoblast syncytialization. Using cell culture 
models, we show that LSD1 is important for human trophoblast syncytialization. Cellular 
signaling, such as the activation of protein kinase A, together with LSD1 contribute to the 
recruitment of GATA2 at the Syncytin-1 and Syncytin-2 loci. Loss of LSD1 in trophoblast cells 
impairs GATA2 function, histone modifications and RNA polymerase II recruitment at Syncytin-
1 and -2 loci leading to their transcriptional repression and impaired syncytialization. In 
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Chapter I: Introduction 
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The hemochorial placenta 
Proper development and maintenance of the human placenta is essential for a healthy, 
successful pregnancy. In addition to being the interface for the exchange of blood, nutrients, 
gases and waste, the placenta protects the fetus from the maternal immune response and secretes 
hormones and growth factors necessary for development [1]. Human chorionic gonadotropin 
alpha and beta (hCGα, hCGβ) are hormones secreted during pregnancy to improve the stability 
of implantation and to establish the proper microenvironment for both the mother and the fetus 
[1, 2].  
Humans possess the invasive hemochorial placenta in which the fetal tissues that branch 
to form villi are in direct contact with maternal blood, thus establishing the maternal-fetal 
exchange surface [3]. While this type of placenta is the most invasive, it provides the smallest 
surface area for exchange [3]. There are three subtypes of hemochorial placenta: 
hemomonochorial with one trophoblast layer, hemodichorial with two layers and hemotrichorial 
with three [4]. The human placenta is classified as villous hemomonochorial [5]. 
In the less invasive endotheliochorial placenta, the endothelial wall of the maternal blood 
vessels separates the fetus from maternal blood after the destruction of the uterine epithelium and 
connective tissue post-implantation [3, 4]. These vessels either remain in a coiled structure or 
they become more parallel and linear as is seen in the hemochorial placenta [6]. The non-
invasive epitheliochorial placenta separates the fetus from maternal blood with three layers of 
tissue because no maternal tissues are destroyed or removed post-implantation [3, 4].  
Further variation in placenta ultrastructure includes the surface area for exchange. Villi, 
which develop from branching fetal tissue, are either surrounded by maternal blood or maternal 
tissue in the villous placenta [3]. The much larger surface area of the labyrinthine placenta is 
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formed by a trophoblast network derived from fetal capillaries and maternal blood [3]. 
Structurally, the trabecular placenta falls in between the villous placenta and the labyrinthine 
placenta [3]. It is thought that the variation in placental ultrastructure is correlated with life 
history and environmental factors [3].  
Since growth, nourishment and survival of the embryo is dependent upon the placenta, 
we need to understand how and where developmental mistakes occur in this organ. As a result of 
elucidating these signaling pathways, we would be able to design therapies for at-risk patients to 




The most important cellular component of the placenta is the trophoblast lineage, which 
is necessary at every stage of fetal and placental development [1]. Soon after ovulation, 
fertilization takes place and cell division begins, leading to a mass of cells called the morula [7]. 
The morula will then make its way from the fallopian tube to the uterine cavity [7]. Implantation 
can occur once the morula has transitioned to a blastocyst [7], where two specific cell types are 
defined. The cluster of cells inside the blastocyst is called the inner cell mass (ICM), which will 
eventually become the fetus [8]. The layer of cells surrounding the blastocyst is the 
trophectoderm (TE), which then gives rise to trophoblast (TB) cells [1, 8, 9]. TB cells produce 
the necessary hormones and cytokines for creating an environment conducive for embryonic and 
placental development, as well as for maternal health [10]. These cells are also responsible for 
expressing receptors that are required for endometrium invasion [10].  
Shortly following implantation to the uterine wall, TB cells begin to differentiate to form 
new TB populations [1]. As differentiation of these cells progresses, a very crucial structure 
unfolds. Villous cytotrophoblast (CTB) cells differentiate into a few different TB populations: 
TB cells that group together form a TB cell column which then makes contact with the maternal 
decidua [1, 9] and extravillous trophoblasts (EVTs) invade the decidua, remodeling maternal 
vascular structure and creating an anchor together with the TB column cells and, consequently, 
the chorionic villi [1, 11]. 
These chorionic villi are tissues made up of mesenchymal cells and are outlined by two 
layers of CTBs [9]. Villous CTBs form the first layer, and when these cells become cell cycle-
terminated, they fuse to form multinucleated syncytiotrophoblasts (STB), completing the 
outermost layer [9]. During the first trimester of pregnancy, CTBs form a distinct layer beneath 
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the STB layer, but further along the developmental timeline, the CTBs become discontinuous 
leaving just the monolayer of STBs [5]. Upon the development of the STB layer, the connection 
between the mother and the fetus is established, providing easy exchange of blood, gases and 
nutrients [1, 8, 11]. 
Human pathologies, such as intrauterine growth retardation (IUGR) and preeclampsia 
(PE), have been linked to syncytial malformation [12]. It has been reported that in PE there is a 
reduction in EVT invasion and placental blood flow, as well as unstable oxygen concentration 
[11]. The role of trophoblast differentiation in placenta development is essential and its 
regulation must be understood in order to investigate methods to improve pregnancy success. 
6 
 
Role of endogenous retroviral proteins in the trophoblast 
Endogenous retroviruses (ERVs) originated as infectious retroviruses which have been 
integrated into human DNA [13, 14]. ERVs can be inherited if they infect the germline and 
colonize, which leads to provirus amplification [14]. These retroviruses are no longer able to 
produce infectious virions due to the vast amount of mutations accumulated over time. They 
have proven to be beneficial to human life, particularly in the context of the placenta, including 
immunosuppressive characteristics that prevent fetal rejection by the mother [13, 14].  
Transcription of ERVs seems to be controlled by DNA methylation patterns which are 
also inheritable [14]. This finding has led to the idea that, through evolution, the need for genetic 
control over ERVs may have been the reason that DNA methylation began [14, 15]. ERV 
envelope proteins, such as placenta-specific Syncytin-1 and Syncytin-2 whose transcription is 
activated upon demethylation [15], contribute their cell-fusion properties to the formation of 
syncytiotrophoblasts [12, 14, 16]. Syncytins are generally silenced until their function is required 
for syncytialization and maintenance of the STB layer [11].  
Many studies have been devoted to understanding the regulation of these Syncytin genes 
since they play such a crucial role in trophoblast syncytialization. It has been shown that cyclic 
adenosine monophosphate (cAMP)-induced differentiation of human CTBs and BeWo cells 
results in the significant upregulation of Syncytin genes, and that transcription factor GATA2 
shows similar expression patterns [17, 18]. In addition, transcription factor GCM1 activates 
Syncytin gene expression, which appears to enhance trophoblast syncytialization. This is 




Errors in the regulation of Syncytins, and thereby syncytin-mediated cell fusion, have 
been implicated in PE, IUGR and Hemolysis Elevated Liver Enzymes and Low Platelets 
(HELLP) syndrome [11]. Langbein et.al showed that the loss of Syncytin expression leads to 
impaired STB formation or no STB formation in these pathological placentas. Also, levels of 
GCM1 and hCGβ expression are diminished in PE/IUGR placentas, and even further 
downregulation of hCGβ is seen in HELLP/IUGR placentas [11]. It has been suggested that an 
accumulation of CTBs occurs where STB development is hindered due to the loss of regulation 
of Syncytin genes in these pathological placentas [11]. Therefore, retroviral proteins Syncytin-1 
and Syncytin-2 are absolutely necessary for successful placentation.   
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Epigenetic regulation of trophoblast syncytialization 
Epigenetics is the change in gene expression patterns that is unrelated to genomic 
changes [19]. Epigenetic changes can be inherited but they can also happen due to an 
environmental factor [19]. The most common examples are DNA methylation and histone 
modification, the latter achieved by methylation, acetylation, phosphorylation, ubiquitination and 
sumoylation [19]. DNA methyltransferases typically methylate DNA at sites where there is a 
high quantity of CpG dinucleotides [19]. Various enzymes are involved in histone modification, 
including methyltransferases and demethylases, depending on the type of modification necessary 
[19, 20]. There are specific sites on histone tails where these modifications can take place, 
namely arginine or lysine side chains, and modifications at these sites can be associated with 
either transcriptional repression or activation [20-22]. Epigenetic modifications have been 
discovered to be important mechanisms in several instances, such as disease progression and 
embryonic development [23].  
In order to address pregnancy failure caused by errors in placental development and 
maintenance, we first needed to understand how these processes are regulated. TB development 
and differentiation is controlled by transcriptional regulation. However, TB regulatory 
mechanisms in humans are currently unknown. Chromatin modification is known to be a key 
factor in trophoblast differentiation [9]. We hypothesized that epigenetic modifier LSD1, along 
with transcription factor GATA2, plays an imperative role in regulating trophoblast 
syncytialization.  
LSD1 has been implicated in mouse trophoblast stem cell (mTSC) differentiation. 
Previously, Zhu et.al, showed that mouse embryos were dying before embryonic day 7.5 (E7.5) 
upon depletion of LSD1. In trophoblast-specific LSD1 knockout embryos, there were major 
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morphological defects, but the embryos displayed delayed lethality. This phenotype reveals 
LSD1 as an important factor in trophoblast development and maintenance for the survival of an 
embryo [24].  
LSD1 is a histone H3 lysine 4 and lysine 9 (H3K4, H3K9) demethylase, and is unique in 
its mechanism of demethylation [20-22]. This particular histone demethylase is a monoamine 
oxidase which operates in the presence of the cofactor Flavin adenine dinucleotide (FAD) by 
means of an oxidation-reduction of FAD [20, 21, 25]. Since H3K4 is an activation mark, 
demethylation at this site results in transcriptional repression. Conversely, H3K9 is a repressive 
mark and demethylation leads to transcriptional activation [20-22, 25]. These post-translational 
modifications determine which genes are to be expressed or repressed.  
Based on our findings, transcription factor GATA2 appears to interact with LSD1, in that 
its expression is downregulated upon knockdown of LSD1, and LSD1 is reduced with GATA 
inhibition. GATA2 is involved in early trophoblast differentiation [17] and is maintained 
throughout placenta maturation. In the mouse, Gata2 has been shown to regulate the 
differentiation of mTS cells to TB giant cells [26, 27, 28]. Thus, we hypothesized that GATA2 
may also play a role in regulating human TB syncytialization. The fate of the embryo is 




In this study, we have been able to elucidate a signaling pathway by which epigenetic factor 
LSD1, in combination with GATA2, controls the expression of Syncytin-1 in order to 























Chapter II: Results and Methods
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Role of LSD1 in trophoblast stem cell differentiation and migration.  
 It has been established that LSD1 is essential for proper trophoblast differentiation and 
migration in the mouse [24]. Zhu et.al, demonstrated that a complete knockout of LSD1 lead to 
early embryonic death but the proper cell lineages were present. An epiblast-specific knockout 
resulted in delayed lethality with relatively normal morphological features until eventual death 
before E8.5, which lead to the idea that LSD1 must play an essential role in extraembryonic 
tissues [24]. Following that result, they developed a trophoblast-specific knockout mouse and 
observed severe morphological defects before embryonic death at E8.5 [24]. 
 Lack of LSD1 in mTSCs caused the cells to exhibit abnormal characteristics. Cell size 
increased quickly and there appeared to be a loss of control over trophoblast migration and 
invasion, which is indicative of early differentiation onset [24]. Because of the large amount of 
endometrium invasion, proliferation of TSCs is greatly reduced leading to a loss of placental 
tissues [24]. Interestingly, re-expression of LSD1 rescued TSC migration, bringing it back to an 
appropriate level [24]. The representative gene expression patterns of differentiation were also 
altered in LSD1-deficient cells, but did not affect stemness-associated gene expression profile 
[24]. Moreover, LSD1 appears to be responsible for the fate of TSCs, which suggests that LSD1 
is not only required for proper timing of differentiation but also for differentiation into the 
correct cell type [24].  
 Based on these results, it would seem that LSD1 plays a role in controlling 
differentiation-associated gene expression in TSCs. This finding provides evidence of the 
importance of epigenetic control throughout development, beginning with initiation of 




LSD1 is important for trophoblast syncytialization. 
 LSD1 is present in the cytotrophoblast and syncytiotrophoblast layers of placental tissues 
during all three trimesters, indicating relevance of this protein in placental development and 
maintenance (Figure 1A-C). In BeWo cells, LSD1 localizes in the nucleus which is consistent 
with its function in chromatin modification (Figure 1D). Typically, BeWo cells form 
multilayered colonies as they grow in vitro. Treatment of BeWo cells with 8-Br-cAMP for 48 
hours in culture causes a monolayer, differentiation-like morphological change (Figure 2A) 
which, in this cell type, indicates syncytialization [29].  
Syncytialization occurs when cell cycle-terminated cytotrophoblasts fuse to form 
multinucleated syncytiotrophoblasts [9]. Prior to this cell-cell fusion, retroviral proteins 
Syncytin-1 and Syncytin-2 are expressed, signaling the cells to undergo syncytialization [16]. 
This process leads to large amounts of hCGα and hCGβ production which further reveals the 
beginning of placenta formation [1, 2]. Upregulation of Syncytin-1, Syncytin-2, hCGα and hCGβ 
was seen in the cells which were treated with 8Br-cAMP when their expression was measured by 
q-PCR (Figure 2B). Notably, LSD1 protein expression level is not altered due to the 8Br-cAMP 







Figure 1. LSD1 is maintained in cytotrophoblast and syncytiotrophoblast populations 
throughout placental maturation. 
Immunohistochemistry staining showing LSD1 in first trimester (A), second trimester (B) and 
term (C) human placenta tissues. Red arrowhead, CTB; yellow arrowhead, SynTB. (D) 







Figure 2. 8Br-cAMP induces syncytialization in BeWo cells.  
(A) Morphological change in BeWo cells when treated with 8Br-cAMP. (B) mRNA expression 
of syncytialization-associated genes and with or without 8Br-cAMP. (C) Protein expression of 





Depletion of LSD1 represses syncytialization-associated genes.  
 To expand upon the involvement of LSD1 in syncytialization, LSD1 was depleted in 
BeWo cells via lentiviral transduction. The shRNA-mediated knockdown of LSD1 showed a 
nearly 10-fold decrease in RNA expression (Figure 3A), and appeared just as efficient when 
protein expression was visualized by western blotting (Figure 3B). LSD1 expression was not 
rescued by treating the LSD1-deficient cells with 8Br-cAMP, just as the treatment in normal 
BeWo cells did not alter the level of LSD1 (Figure 3B).  
In order to assess the loss of LSD1 in relation to syncytialization, the syncytin and hCG 
gene expression was measured by qPCR. Reduction in the expression of syncytin genes hinders 
syncytiotrophoblast formation [16]. In the absence of LSD1, Syncytin-1 and Syncytin-2 were 
greatly reduced (Figure 3C). Expression levels of hCGα and hCGβ were also decreased when 
LSD1 was knocked down (Figure 3D). This reduction in expression of Syncytin-1, Syncytin-2, 
hCGα and hCGβ is evidence that the occurrence of syncytialization is impaired upon depletion 









Figure 3. LSD1 is required for trophoblast syncytialization.  
mRNA expression (A) and protein expression (B) of LSD1 with or without 8Br-cAMP 
treatment; LSD1 knockdown by lentiviral transduction. (C) mRNA expression of Syncytin-1 and 
-2, and (D) hCGα and hCGβ, in BeWo cells treated with 8Br-cAMP versus LSD1-knockdown 
BeWo cells treated with 8Br-cAMP, normalized to untreated control.  
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LSD1 alters chromatin state and gene expression profile. 
 To investigate the histone demethylase properties of LSD1 in the context of 
syncytialization, we utilized chromatin immunoprecipitation for the methylated histone marks in 
the BeWo/LSD1-KD model. Where LSD1 is present at normal levels, RNA Polymerase II is 
recruited at Syncytin-1 and Syncytin-2 loci upon 8Br-cAMP treatment, while there is no 
recruitment of RNA Polymerase II where LSD1 has been knocked down (Figure 4A-B). In this 
context, RNA Polymerase II is recruited to Syncytin genes to catalyze transcription, but only 
when syncytialization is induced and LSD1 is expressed at normal levels.   
Upon induction of syncytialization by treatment with 8Br-cAMP, there were lower levels 
of di- and monomethylated H3K9 as compared to the untreated condition at Syncytin-1, 
Syncytin-2, hCGα and hCGβ (Figures 4C and 4E). Interestingly, treatment with 8Br-cAMP in 
LSD1-KD cells showed an increase in di- and monomethylation at the genes listed when 
compared to the 8Br-cAMP treated control BeWo cells (Figure 4D and 4F). More specifically, 
these genes were repressed under normal conditions but induction of syncytialization 
derepressed these genes. Loss of LSD1 caused the opposite effect, in that these genes remained 
repressed even though PKA was activated by the 8Br-cAMP treatment. Therefore, histone 












Figure 4. LSD1 is required for H3K9 demethylation and subsequent expression of 
syncytialization-associated genes.  
RNA Polymerase II recruitment at Syncytin-1 and Syncytin-2 in 8Br-cAMP treated BeWo cells, 
normalized to untreated control (A). Loss of RNA Polymerase II recruitment in 8Br-cAMP 
treated LSD1-KD BeWo cells (B). H3K9me2 (C) and H3K9me (E) methylation levels in 8Br-
cAMP treated BeWo cells. H3K9me2 (D) and H3K9me (F) methylation levels in 8Br-cAMP 
treated LSD1-KD BeWo cells, normalized to 8Br-cAMP treated BeWo cells.  
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Inhibition of LSD1 in term cytotrophoblasts impairs syncytialization. 
 Cytotrophoblasts isolated from a human term placenta were cultured for expression 
analysis. In culture, these cells fuse when in close proximity to each other, producing hCGα and 
hCGβ. LSD1 appeared to be present in a reasonably high quantity when its expression was 
measured by qPCR (Figure 5A). When the term cytotrophoblasts were treated with 
Tranylcypromine (TCP), an LSD1 inhibitor, they did not exhibit characteristics of cell fusion in 
that there was a decrease in Syncytin-1, hCGα and hCGβ expression after LSD1 inhibition 
(Figure 5A), revealing the necessity of LSD1 function for the formation of syncytiotrophoblasts. 
Additionally, the amount of di- and monomethylated H3K9 was much higher at hCGα and hCGβ 
loci when LSD1 was inhibited (Figures 5B-C). This further supports the idea that 









Figure 5. Inhibition of LSD1 prevents syncytialization in human term cytotrophoblasts.  
mRNA expression of LSD1, Syncytin-1, hCGα and hCGβ in term CTBs treated with LSD1 
inhibitor TCP, normalized to vehicle control (A). H3K9me2 (B) and H3K9me (C) methylation 




GATA2 plays a role in LSD1 regulation of syncytialization. 
 Transcription factor GATA2 is important for early trophoblast differentiation [17, 26-28, 
30]. Though the amount of GATA2 expression declines over time during placenta formation, it 
remains present in the syncytiotrophoblast layer during all three trimesters of pregnancy (Figure 
6A). Relevance of GATA2 during development is well studied, however its role is yet to be 
established in regards to human trophoblast syncytialization.  
 To further understand the involvement of GATA2 in regulation of syncytialization, we 
first explored the relationship between GATA2 and LSD1. Where LSD1 was knocked down, 
GATA2 expression was also reduced (Figures 6B and 6D), even with 8Br-cAMP treatment 
(Figure 6C-D). Chromatin immunoprecipitation showed recruitment of GATA2 at Syncytin-1 and 
Syncytin-2 loci when syncytialization was induced by 8Br-cAMP treatment (Figure 7A), while 
there was a major loss of GATA2 recruitment in the absence of LSD1 in the treated cells (Figure 
7B). Using a GATA-specific inhibitor, K-7174, BeWo cells were treated with either DMSO, 
8Br-cAMP or both 8Br-cAMP and K-7174. The combined treatment resulted in a 
downregulation of LSD1 and Syncytin-1 (Figure 7C). Further, the amount of H3K9 di- and 
monomethylation at the GATA2 locus decreases upon 8Br-cAMP treatment as compared to the 
level of methylation in the untreated BeWo sample (Figures 7D and 7F). In the absence of LSD1, 
methylation at GATA2 increases with the 8Br-cAMP treatment, relative to the 8Br-cAMP 
treated BeWo cells where LSD1 function is maintained (Figures 7E and 7G). Together, our data 
defines a clear relationship between LSD1 and GATA2 that has an impact on the function of 







Figure 6. The interrelationship of GATA2 and LSD1.  
GATA2 staining in first trimester (A1), second trimester (A2) and term (A3) human placenta. 
mRNA expression of GATA2 in LSD1-KD cells, normalized to Scramble control (B), and in 
8Br-cAMP treated LSD1-KD BeWo cells, normalized to 8Br-cAMP treated Scramble control 
(C). Protein expression of GATA2 in BeWo cells with or without 8Br-cAMP treatment vs. 










Figure 7. Trophoblast syncytialization and associated gene expression is GATA2-
dependent.  
GATA2 recruitment at Syncytin-1 and Syncytin-2 in 8Br-cAMP treated BeWo cells, normalized 
to untreated control (A), and in 8Br-cAMP treated LSD1-KD cells, normalized to 8Br-cAMP 
treated BeWo cells (B). mRNA expression of LSD1, Syncytin-1 and Syncytin-2 in BeWo cells 
treated with GATA inhibitor K-7174, normalized to vehicle control (C). H3K9me2 (D) and 
H3K9me (F) methylation levels at GATA2 in 8Br-cAMP treated BeWo cells, normalized to 
untreated control. H3K9me2 (E) and H3K9me (G) methylation levels at GATA2 in 8Br-cAMP 




MATERIALS & METHODS 
Cell culture and reagents. BeWo human choriocarcinoma cells were cultured in DMEM F12 
medium with L-Glutamine, 15 mM HEPES, 10% fetal bovine serum and primocin (2 uL/mL). 
For inducing syncytialization, BeWo cells were cultured for 24 hours and then treated with 250 
uM 8-Bromoadenosine 3’,5’-cyclic monophosphate (Sigma) for 48 hours.  
 Human term CTBs were cultured in IMDM medium with 10% fetal bovine serum, 1% L-
Glutamine and 1% Pen-strep. Cells were collected at 24 hours for non-syncytialized CTB 
population. Cells were cultured for 4-5 days for syncytiotrophoblasts. For inhibition of LSD1, 
CTBs were immediately treated with 500 uM Tranylcypromine, HCl (Millipore) and cultured for 
aforementioned amounts of time.  
 
Isolation of CTBs from human term placenta. Human placenta is obtained following a 
cesarean section birth. Process is modified from a published protocol. Tissue was washed using 
1X saline and dried on cheesecloth. Tissues were scraped from the chorionic membrane and 
placed in 1X saline for further washing. After 50 g of tissue was dried and digested in Q-water 
with 100 mg trypsin, 10 mL dispase, 40 mg DNase and 25 mL 10X Hanks buffered with HEPES 
for a total volume of 250 mL. Digestion should take place in a shaker incubator at 37℃ at ~200 
rpm for 1 hour, but add additional 20 mg trypsin and 20 mg DNase after the first 30 minutes. The 
contents were then filtered into 50 mL fetal bovine serum and then subjected to a series of 
centrifugation. Pellets were resuspended in DMEM with 10% FBS and added to discontinuous 
percoll gradient, followed by centrifugation. Trophoblast cells can be identified by density and 
extracted for use in experiments.  
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qPCR. RNA was extracted from cells with the TRIzol reagent (Sigma) and used to synthesize 
cDNA. Analysis achieved by quantitative Real-time PCR (Applied Biosystems).  
Primer  Exons Forward Sequence 
Reverse Sequence 
LSD1 Ex2/3 GAA GAG AGA AAT GCC AAA GCA 
CGT CTC CAT ACC CTC CAG AA 
Syncytin-1  CTA CCC CAA CTG CGG TTA AA 
GGT TCC TTT GGC AGT ATC CA 
Syncytin-2  CCA AAT TCC CTC CTC TCC TC 
CGG GTG TTA GTT TGC TTG GT 
hCGα Ex2/3 TCT GGT CAC ATT GTC GGT GT 
TTC CTG TAG CGT GCA TTC TG 
hCGβ Ex2/3  GTG TGC ATC ACC GTC AAC AC 
GGT AGT TGC ACA CCA CCT GA 
GATA2 Ex4/5  CTC ATC AAG CCC AAG CGA AG 
ACA ATT TGC ACA ACA GGT GCC 
GCM1 Ex3/4  GGC GCA AGA TCT ACC TGA GA 
CAC AGT TGG GAC AGC GTT T 
 
 
Quantitative ChIP. Cells were collected and protein-DNA cross-linking was achieved by 
treating the cells with 1% formaldehyde (Sigma) for 10 minutes at room temperature with gentle 
rocking. 125 mM Glycine was added to quench the reaction. Chromatin immunoprecipitation 
was completed following a previously established protocol. Immunoprecipitation with different 
antibodies: Gata2 (abcam), H3K9me (abcam), H3K9me2 (abcam), RNA Pol II (Covance) and 
Mouse IgG (BD Bioscience) was used as a negative control for antibody binding. After 
immunoprecipitation, chromatins were reverse cross-linked, digested with proteinase K (Sigma) 
and purified. Amplification by real-time PCR was used to quantify precipitated DNA. A standard 
curve was set using input DNA samples at concentrations of ⅕, 1/25, 1/125 and 1/625.  
ChIP Primer Location Forward Sequence 
Reverse Sequence 
Syncytin-1 -1kb GGA GAC TTG TGG CTG TCA GA 
AGC ACT GGC CCT TCA AGT AA 
29 
 
Syncytin-2 -1kb CAA CAC AAA TAG ATT TCA AAA GCA 
TGT AAA TCA AAT CAC ACA ACA TGC 
hCGα -1kb GCC AAC ATG GTG AAA CTC CT 
AGC TGG GAC TAC AGG TGT GC 
hCGβ -1kb CAC ATG TGG TTT TGA AGG TTG 
CAT CAT GAT TAC CCT CAA GTT CC 
GATA2 -500bp CTG ATT GTA TGG CCA TGT GTG 
GCG AGG ACA TCC TCA GAC AG 
GCM1 -1kb AAG GCC TGG CAG ACT ACC TA 
AGA TTG CGT CAC TGC AGT CA 
GCM1  -500bp AGG ATG TTG GCT ATC CAC TGT C 
TCT CTC TCA TGT GTG CAA GAG A 
 
 
Western blot analysis. Whole-cell lysates were extracted with a lysis buffer. Electrophoresis 
was performed using a 10-12% polyacrylamide gel in Tris-glycine running buffer (pH 8.3). 
Proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). Blocking 
was performed with 5% nonfat dry milk (Difco) in 20 mM Tris-HCl, pH 7.6 (Tris-buffered 
saline with Tween [TBS-T]). Primary antibody incubation, washing, secondary antibody 
incubation and development of chemiluminescent signals were done following a previously 
published protocol. The HRP substrate used was Luminata crescendo (Millipore).  
 
Immunofluorescence. Procedure was adapted from a previously published protocol. Cells were 
washed with PBS and fixed on glass coverslips with 4% paraformaldehyde (Sigma) in PBS. 
Cells were permeabilized in 0.25% Triton X-100 in PBS and blocked with 10% FBS in PBS with 
1% Triton X-100. Primary antibody incubation was completed in 1 hour, followed by washing 
with 0.05% Triton X-100 in PBS and then secondary antibody (conjugated with Alexa fluor 488 
[green]) incubation for 30 minutes while shielded from light. Next, the cells were counterstained 
30 
 
with DAPI (Invitrogen) and observed under a fluorescence microscope (Leica). All incubations 
took place at room temperature.  
shRNA knockdown via lentiviral transfection. Short hairpin RNAs (shRNAs) targeting human 
LSD1/Kdm1a (Sigma). Lentiviral supernatants were prepared in HEK293T cells following a 
previously described procedure. Five different shRNA constructs were used. shRNA construct 
068 was the most effective for the knockdown of LSD1. Lentiviral particles were transduced in 
BeWo cells and selected with puromycin in BeWo culture condition. Experimental analyses 
were performed after 3-4 days of culture.    
 
Immunohistochemistry. Human placental FFPE sections were deparaffinized and rehydrated 
using Histoclear (National Diagnostics) followed by decreasing ethanol gradient and distilled 
water. Antigen retrieval was done using Reveal Decloaker in the Decloaking chamber (Biocare 
Medical) at 90℃ for 15 minutes. Peroxidase blocking was done using 3% hydrogen peroxide for 
10 minutes at room temperature, followed by blocking for nonspecific binding with 10% Normal 
Goat Serum (Invitrogen) for 30 minutes. Primary antibody and secondary antibody incubations 
were done for 30 minutes using antibody dilution buffer (1% BSA, 0.3% Tween 20 in PBS (pH 
8.0)) for secondary antibody (biotinylated anti-rabbit or mouse IgG (H+L) [Vector] with 0.05% 
Normal human serum). Tissues were incubated with HRP-streptavidin (Life Technologies) for 
10 minutes, followed by DAB chromogen solution (Dako) for color change and Mayer’s 
Hematoxylin solution (Sigma) for 5 minutes. Hematoxylin color change was achieved using 
warm, running tap water for approximately 2 minutes. Dehydration of the tissue was achieved 
using distilled water, increasing ethanol gradient and Xylene. Stained tissues were imaged using 























Chapter III: Discussion and Future Perspectives
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Epigenetic modifier LSD1 plays a major role in the regulation of human trophoblast 
syncytialization. Expression of the retroviral proteins Syncytin-1 and Syncytin-2 initiates cell 
fusion, or syncytialization, in cell cycle-terminated cytotrophoblasts [16, 31]. In addition to 
activation of Protein Kinase A (PKA), this cellular signal is critical to the proper development of 
the human placenta and, ultimately, growth and survival of the fetus. Alterations in the 
epigenome appear to be sufficient in shutting down transcription and further signaling in this 
developmental process.  
BeWo cells, in lieu of primary cytotrophoblasts, exhibit nuclear expression of LSD1 and 
mimic trophoblast syncytialization. 8Br-cAMP treatment in BeWo cells causes an increase in 
cytosolic cAMP concentration, triggering the activation of PKA [29]. Based on our findings, 
PKA activation appears to be the initial signal which changes the cellular environment, leading 
to the signaling cascade that initiates syncytialization. The amount of LSD1 is not affected by the 
8Br-cAMP treatment, but its histone modification activity seems to respond to the activation of 
PKA. For our purposes, it looks as if hCGα and hCGβ are expressed during syncytialization. 
When LSD1 is significantly reduced or inhibited, the expression of these syncytialization-
associated genes is greatly impacted, which offers the possibility that LSD1 is involved in the 
initiation of syncytialization.  
 The importance of LSD1 becomes clear when it is knocked down in BeWo cells. 
Syncytin genes are unable to activate without a sufficient level of LSD1 present. Hormone 
secretion that is essential to the pregnancy microenvironment also does not occur properly in this 
condition. Treating the LSD1-KD cells with 8Br-cAMP reveals the necessity of LSD1 in this 
signaling pathway where its demethylase function is pertinent. Seemingly, Syncytin-1 
transcription is prevented in an LSD1-deficient environment because RNA Polymerase II is not 
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recruited at the Syncytin-1 locus in these conditions. To further assess the importance of LSD1, 
it is necessary to understand its histone demethylation properties.   
Histone demethylation is a key post-translational modification that is a crucial step in our 
proposed signaling mechanism. Many histone demethylases have been reported and shown to be 
instrumental in altering gene expression without changing the genome [25]. In relation to altering 
expression of syncytialization-associated genes, LSD1 appears to be associated with repressive 
chromatin, specifically histone H3 lysine 9-methylation. 8Br-cAMP treatment results in a 
decrease in the level of H3K9 methylation at syncytialization-associated gene loci, suggesting 
that LSD1 is removing the methyl groups in response to PKA activation, which then leads to the 
expression of Syncytin proteins to initiate syncytialization. When LSD1-KD cells are treated 
with 8Br-cAMP in an attempt to force syncytialization, methylation increases which results in 
repression of the genes necessary for syncytialization. As the number of methyl groups at one 
site increases, so does the level of repression [25]. Our findings have definitively shown that an 
increase in H3K9-methylation causes suppression of Syncytin-1, Syncytin-2, hCGα and hCGβ in 
the absence of LSD1. Thus, H3K9 demethylation by LSD1 results in an entirely different gene 
expression profile compared to one which lacks LSD1, suggesting that epigenetic modification 
provides a significant means of regulation in this context.  
Furthermore, small molecule inhibition of LSD1 demonstrates similar results to the 
knockdown experiment. Primary cytotrophoblasts express LSD1, as determined visually by 
staining placenta tissues and quantitatively when cultured in vitro. Loss of LSD1 activity 
prevents syncytialization in primary cells, as observed by loss of Syncytin-1, hCGα and hCGβ 
expression. As seen in the BeWo cells, levels of mono- and dimethylation at hCGα and hCGβ 
increase significantly where LSD1 activity is inhibited in cytotrophoblasts, which is consistent 
34 
 
with our finding that LSD1 is important for allowing expression of syncytialization-associated 
genes.  
 In continuing the mechanistic investigation of human trophoblast syncytialization, we 
have found that transcription factor GATA2 is involved. Previous studies have shown the 
importance of GATA2 in early trophoblast differentiation [26-28], which gives rise to the 
question of whether it is also a regulator of trophoblast syncytialization. Based on our data, there 
appears to be a mutual relationship between LSD1 and GATA2. GATA2 is recruited at Syncytin-1 
and Syncytin-2 upon induction of syncytialization, suggesting that initiation of syncytialization 
may be GATA2-dependent. Consistent with our findings thus far, the loss of GATA2 recruitment 
at Syncytin-1 and Syncytin-2 where LSD1 is knocked down implies a relationship between 
GATA2 and the LSD1-regulation of Syncytin expression. Further, the increase in methylation at 
GATA2 when LSD1-KD samples are treated with 8Br-cAMP supports the idea that the 
repressive effect on GATA2 is specific to its role in trophoblast syncytialization. GATA 
inhibition leads to a significant down-regulation of LSD1 and Syncytin-1, also leading to the 
conclusion that this process is GATA2-dependent. Syncytin-2 may be regulated by an additional 
transcription factor or mechanism since the data consistently shows overexpression of Syncytin-
2 following GATA inhibition.  
 In summary, the data we present brings to light, for the first time, an epigenetic signaling 
pathway for initiation of human trophoblast syncytialization. In response to the change in cellular 
environment caused by the activation of PKA, GATA2 is recruited at the Syncytin-1 and 
Syncytin-2 loci. Simultaneously, LSD1 is activated and demethylates H3K9 due to the 
requirement of Syncytin-1 and Syncytin-2 mediated cell-cell fusion. This histone modification is 
the key step in this pathway where these essential genes are able to activate and initiate the 
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syncytialization process (Figure 8). Epigenetic regulation has a significant impact on which 
genes are expressed or silenced and how cellular signals are interpreted. Histone demethylases, 
along with many other epigenetic factors, provide a method for approaching pathological 
pregnancies and other pathological conditions caused by particular gene expression patterns 
without altering the genome [19, 23]. For example, this method offers an alternative to gene 
therapy. Prevention of detrimental post-translational modifications or enhancement of beneficial 
changes allows the genome to remain intact while epigenetic manipulations take place, one 
implication being that histone demethylases present a possible platform for drug targeting. 
It is important to continue investigation of signaling pathways which control trophoblast 
differentiation for a more complete understanding of this developmental process. The 
advancement of early detection technology is also necessary. The detrimental effects of 
pathological conditions such as PE, IUGR and HELLP can be severe or even fatal, and some of 
these effects last throughout the entire life of the mother and the child after birth [33]. Detecting 
these complications earlier in the pregnancy may greatly reduce the percentage of failed 
pregnancies [34]. In addition to further mechanistic studies, the development of drugs to target 
epigenetic factors would cause the particular gene to be switched on or off to improve the 
condition [19, 23]. Personalized medicine is another possible treatment option [19], though much 









Figure 8. Summary: LSD1 regulates trophoblast syncytialization via a GATA2-dependent 
pathway. 
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